Pediatrix Medical Group, Inc. (MD) is a publicly traded Healthcare sector company. As of May 21, 2026, MD trades at $22.47 with a market cap of $1.86B and a P/E ratio of 10.71. MD moved -2.06% today. Year to date, MD is +2.60%; over the trailing twelve months it is +48.22%. Its 52-week range spans $11.04 to $24.99. Analyst consensus is buy with an average price target of $23.33. Rallies surfaces MD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Pediatrix Medical Q4 EPS Misses by 4.9%, Revenue Beats Estimate by 0.5%: Pediatrix Medical reported Q4 2025 adjusted EPS of $0.50, missing estimates by 4.9%, while revenues fell 1.7% to $493.8 million but beat the top-line forecast by 0.5%. The company ended the year with $375.2 million in cash and projected 2026 adjusted EBITDA of $280–300 million.
| Metric | Value |
|---|---|
| Price | $22.47 |
| Market Cap | $1.86B |
| P/E Ratio | 10.71 |
| EPS | $2.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.99 |
| 52-Week Low | $11.04 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.93B |
| Net Income | $174.22M |
| Gross Margin | 0.00% |
6 analysts cover MD: 0 strong buy, 2 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $23.33.